20671 ⎘
Medicinal preparations containing materials or reaction products thereof with undetermined constitution; Microorganisms or materials therefrom Viruses; Subviral particles; Bacteriophages
Anti-tumor properties of Dickkopf 3b
#902Antibacterial phage, phage peptides and methods of use thereof
#903Reducing conjugative plasmids in bacteria
#904Recombinant virus products and methods for inhibition of expression of myotilin
#905Directed evolution and in vivo panning of virus vectors
#906Bacteriophages against ssp and their use
#907Probiotic recolonisation therapy
#908Probiotic recolonisation therapy
#909Phage therapy of pseudomonas infections
#910SHIELDED BIOLOGIC THERAPEUTIC
#911Schmallenberg virus (SBV) vaccine, methods of production, and uses thereof
#912PURE FILAMENTOUS BACTERIOPHAGE AND METHODS OF PRODUCING SAME
#913Puma protein expression vector and use thereof in gene therapy
#914Influenza virus mutants and uses therefor
#915Influenza virus mutants and uses therefor
#916Malaria vaccine
#917Regulating calcium in excitable cells with a novel protein
#918AAV's and uses thereof
#919bacteriophages and uses thereof
#920Replication-defective arenavirus vectors
#921Recombinant AAV-crumbs homologue composition and methods for treating LCA-8 and progressive RP
#922Plant produced human papillomavirus pseudovirion
#923Probiotic recolonisation therapy
#924Probiotic recolonisation therapy
#925Probiotic recolonisation therapy
#926Probiotic recolonisation therapy
#927TREATMENT OF INTRACELLULAR BACTERIAL INFECTION
#928Gene-modified coxsackievirus
#929Bacteriophage therapy
#930Myxoma virus mutants for cancer treatment
#931Compositions and methods for enhancing virus replication
#932MESSENGER RNA BASED VIRAL PRODUCTION
#933Methods of using T4 bacteriophage in treatment of adenoviral infections caused by HAdV-5
#934Capsid-modified rAAV vectors and methods of use
#935Hairpin mRNA elements and methods for the regulation of protein translation
#936Extract and preparation containing said extract
#937Bacteriophage and antibacterial composition comprising the same
#938Bacteriophage and antibacterial composition comprising the same
#939Bacteriophage and antibacterial composition comprising the same
#940Bacillus bacteria for use in treating and preventing infection in aquatic animals
#941Bacteriophage and antibacterial composition comprising the same
#942Bacteriophage and antibacterial composition comprising the same
#943Wound healing compositions comprising biocompatible cellulose hydrogel membranes and methods of use thereof
#944Antibacterial phage, phage peptides and methods of use thereof
#945bacteriophage and uses thereof
#946NANOSCALE COATINGS FOR ENCAPSULATION OF BIOLOGICAL ENTITIES
#947Self-complementary parvoviral vectors, and methods for making and using the same
#948Method for prevention and treatment of infection
#949NOVEL PRRS VIRUS INDUCING TYPE I INTERFERON IN SUSCEPTIBLE CELLS
#950Therapeutic viral microparticles for promoting stent biofunctionality and wound healing in vertebrate individuals
#951METHODS AND COMPOSITIONS FOR BACTERIOPHAGE THERAPY
#952Anti-mycobacterial vaccines
#953Antibacterial phage, phage peptides and methods of use thereof
#954BIOADHESIVE AND BIODEGRADABLE AND FORMULATIONS THAT PROVIDE SUSTAINED RELEASE OF ANTIMICROBIALS, BACTERIOPHAGES AND ANTI-INFLAMMATORY MEDICATIONS FOR INACTIVATION OF BIOFILMS AND THE TREATMENT OF RHINOSINUSITIS AND OTHER INFECTIONS
#955Adeno-associated virus variants and methods of use thereof
#956COMPOSITIONS AND METHODS FOR TREATING AN IMMUNODEFICIENCY VIRUS INFECTION
#957Method for promoting the synthesis of collagen and proteoglycan in chondrocytes
#958Compositions and methods for treating MPSI
#959Compositions and methods for promoting growth of beneficial microbes to treat or prevent disease or prolong life
#960Non-covalent loading of plant picornavirus particles
#961Technology for the Preparation of Microparticles
#962Therapeutic compositions and methods for treating infections
#963Codon optimized recombinant phage and methods of using same
#964Respiratory syncytial virus with a genomic deficiency complemented in trans
#965Method for prevention and treatment of infections using a bacteriophage with broad antibacterial spectrum against
#966Powered stowable vehicle seat and associated seat frame assembly
#967Broad Spectrum Bacteriocin for Control of Unwanted Bacteria
#968Influenza viruses with mutant PB2 segment as live attenuated vaccines
#969Method for prevention and treatment of infections
#970Probiotic recolonisation therapy
#971Probiotic recolonisation therapy
#972Probiotic recolonisation therapy
#973Prebiotic compositions comprising one or more types of bacteriophage
#974COMPOSITIONS FOR THE RESTORATION OF A FECAL MICROBIOTA AND METHODS FOR MAKING AND USING THEM
#975Therapeutic bacteriophages
#976COMPOSITIONS AND METHODS FOR TREATING PROTEINOPATHIES
#977Human Betacoronavirus lineage C and identification of N-terminal dipeptidyl peptidase as its virus receptor
#978Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
#979Treatment of intracellular bacterial infection
#980AAV vectors targeted to oligodendrocytes
#981Probiotic recolonisation therapy
#982Enhanced adoptive cell therapy
#983Lyophilized viral formulations
#984Liquid viral formulations
#985ANTI-BACTERIA COMPOSITIONS
#986Filaments Comprising a Microorganism and Method for Making Same
#987Method of evaluating the therapeutic efficacy of bacteriophages
#988Replication competent pseudo-type retrovirus vector system
#989Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#990Method of stimulating an immune response using a pseudotyped lentivirus
#991Anti-tumor properties of Dickkopf 3b
#992Papillomavirus pseudoviruses for detection and therapy of tumors
#993Compositions comprising cocktails of antibacterial phages and uses thereof for the treatment of bacterial infections
#994Recombinant herpes virus and pharmaceutical composition containing the same
#995COMPOSITIONS AND METHODS FOR TARGETED GENE DISRUPTION IN PROKARYOTES
#996Mutant adeno-associated virus virions and methods of use thereof
#997Bacteriophage for biocontrol of and in the manufacturing or processing of foods
#998Therapeutic bacteriophage compositions
#999Process for producing poxviruses and poxvirus compositions
#1000Filamentous bacteriophage as an angiogenesis modulator
#1001Fast Diagnosis and Personalized Treatment for Acne
#1002Bacteriophages expressing antimicrobial peptides and uses thereof
#1003METHODS AND DELIVERY SYSTEM FOR BENEFICIAL ADDITIVE AND SUBTRACTIVE BIOLOGICAL AGENTS TO PROMOTE BALANCED MAMMALIAN GASTROINTESTINAL FLORA
#1004Delivery of packaged RNA to mammalian cells
#1005Bacteriophage preparations and methods of use thereof
#1006Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#1007bacteriophage P825 and uses thereof
#1008Cancer therapy with a parvovirus combined with an HDAC inhibitor
#1009Method for treatment of type K99 infections
#1010Bacteriophage having bactericidal activity with respect to
#1011Method for preventing and treating Typhimurium infection
#1012Isolated bacteriophage having -specific bactericidal activity and antibacterial composition comprising the same
#1013Bacteriophage and antibacterial composition comprising the same
#1014METHOD OF CONTROLLING TOMATO PLANT VIRUSES
#1015NEURODEGENERATIVE DISEASES AND METHODS OF MODELING
#1016Bacteriophages
#1017Mutant replicon derived from genome of hepatitis C virus J6CF strain
#1018METHOD FOR THE USE OF NITRATE REDUCING BACTERIA AND PHAGES FOR MITIGATING BIOGENIC SULFIDE PRODUCTION
#1019Wound healing compositions
#1020Edible web comprising microorganisms
#1021APC-mediated tolerance induction for therapy of multiple sclerosis
#1022Adeno-associated virus virions with variant capsid and methods of use thereof
#1023LOCATION-SPECIFIC BACTERIAL MANAGEMENT
#1024Immunogenic combination compositions and uses thereof
#1025Bacteriophage with activity against pathogenic strains of
#1026bacteriophage compositions and uses thereof
#1027ANTI-TUMOR COMPOSITION
#1028Delivery of viral agents
#1029Controlled covalent attachment of bioactive bacteriophage for regulating biofilm development
#1030Method for the treatment of tuberculosis
#1031Methods and compositions for production of vaccinia virus
#1032Recombinant rift valley fever (RVF) viruses and methods
#1033Desiccated biologics and methods of preparing the same
#1034Compositions containing protein polymers and vaccinia virus, and methods of use thereof
#1035Method for treating neurodegenerative tauopathy
#1036Methods and compositions for treating tumors using myeloid derived suppressor cells
#1037Antibacterial phage, phage peptides and methods of use thereof
#1038Methods and compositions for pseudoinfectious alphaviruses
#1039Control apparatus and method, recording medium and program
#1040BENEFICIAL EFFECTS OF BACTERIOPHAGE TREATMENTS
#1041Human antibodies and antibody-drug conjugates against CD74
#1042Methods and compositions for dengue virus 3 (DV3) infectious clone
#1043Bacteriophage and antibacterial composition comprising the same
#1044Antinematodal methods and compositions
#1045MYXOMA VIRUS MUTANTS FOR CANCER TREATMENT
#1046Schmallenberg virus (SBV) vaccine, methods of production, and uses thereof
#1047Infectious Schmallenberg virus from cloned CDNAS and uses thereof
#1048Bacteriophage and its use for preventing proliferation of pathogenic bacteria
#1049Bacteriophages for reducing toxicity of bacteria
#1050Growth-regulated viral vector containing the aurora kinase promoter
#1051PVRL4 (Nectin4) is a receptor for measles virus
#1052Treatment of Sanfilippo syndrome type B by intrathecal administration of alpha-n-acetylglucosaminidase
#1053Poxviral oncolytic vectors
#1054BACTERIOPHAGE KILLING PSEUDOMONAS AERUGINOSA AND STAPHYLOCOCCUS AUREUS
#1055Methods for attenuating virus strains for diagnostic and therapeutic uses
#1056METHODS AND COMPOSITIONS FOR THE TREATMENT OF CIRRHOSIS AND LIVER FIBROSIS
#1057Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
#1058Recombinant retrovirus pseudotyped with a E2 alphavirus glycoprotein
#1059Influenza viruses with mutant PB2 gene segment as live attenuated vaccines
#1060Papillomavirus pseudoviruses for detection and therapy of tumors
#1061Compartmentalized method of nucleic acid delivery and compositions and uses thereof
#1062Bacteriophage-containing therapeutic agents
#1063Methods of producing influenza vaccine compositions
#1064SYSTEM COMPRISING BACTERIOPHAGES AND PARTICLES THAT CONTAIN ACTIVE SUBSTANCES
#1065METHOD FOR TREATING INFLAMMATION ASSOCIATED WITH AMYLOID DEPOSITS AND BRAIN INFLAMMATION INVOLVING ACTIVATED MICROGLIA
#1066REDUCTION IN BACTERIAL COLONIZATION BY ADMINISTERING BACTERIOPHAGE COMPOSITIONS
#1067Excipients for Stabilising Viral Particles, Polypeptides or Biological Material
#1068Method of preventing or treating influenza A viral infection using cloned DI influenza A viral particles
#1069INFLUENZA VIRUS POPULATIONS, METHODS OF USE AND METHODS OF MAKING THEREOF
#1070MODIFIED INFECTIOUS LARYNGOTRACHEITIS VIRUS (ILTV) AND USES THEREOF
#1071Stabilisation of viral particles
#1072Microorganisms for imaging and/or treatment of tumors
#1073BACTERIOPHAGES FOR USE AGAINST BACTERIAL INFECTIONS
#1074Vaccine for enveloped viruses
#1075PURE FILAMENTOUS BACTERIOPHAGE AND METHODS OF PRODUCING SAME
#1076ANTI-TUMOR COMPOSITION
#1077Genetically modified paramyxovirus for treatment of tumor diseases
#1078Recombinant herpes virus and pharmaceutical composition containing the same
#1079Tumor specific promoter and oncolytic virus vector comprising the same
#1080Cancer Therapy with a Parvovirus Combined with an HDAC Inhibitor
#1081POXVIRAL ONCOLYTIC VECTORS
#1082PRRS virus inducing type I interferon in susceptible cells
#1083Adenovirus E1A fragments for use in anti-cancer therapies
#1084Bacteriophage and antibacterial composition comprising the same
#1085Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment of Alopecia
#1086Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment Of Dermatology Related Genetic Diseases
#1087Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For the Treatment of Psoriasis
#1088Method for Prevention and Treatment of Salmonella Infection
#1089DEFINED DOSE THERAPEUTIC PHAGE
#1090bacteria for use in treating and preventing infection in aquatic animals
#1091Control apparatus and method, recording medium and program
#1092BACTERIOPHAGES EXPRESSING AMYLOID PEPTIDES AND USES THEREOF
#1093Process for producing poxviruses and poxvirus compositions
#1094ENCAPSULATED BACTERIOPHAGE FORMULATION
#1095Microorganisms for imaging and/or treatment of tumors
#1096Wound healing compositions comprising biocompatible cellulose hydrogel membranes and methods of use thereof
#1097INTRANASAL SPRAY-TYPE TUBERCULOSIS VACCINE USING PARAMYXOVIRUS VECTOR
#1098VIRUS GROWING IN HYPOXIC CELL OR VIRUS VECTOR EXPRESSING GENE THEREIN
#1099RECOMBINANT POXVIRUS EXPRESSING HOMOLOGOUS GENES INSERTED INTO THE POXVIRAL GENOME
#1100METHOD FOR USING LIBERATED DORMANT BACTERIOPHASE AND ENVIRONMENTAL STRESS TO REDUCE INFECTIOUS BACTERIA
#1101PSEUDOMONAS AERUGINOSA BACTERIOPHAGE(S) AND USES THEREOF
#1102Adeno-associated virus virions with variant capsid and methods of use thereof
#1103Bacteriophage of the siphoviridae family and antibacterial compositions comprising the same
#1104DRUG COMPOSITION FOR ANGIOGENESIS THERAPY
#1105Viruses for the treatment of cellular proliferative disorders
#1106Reduction In Bacterial Colonization By Administering Bacteriophage Compositions
#1107Technology for the Preparation of Microparticles
#1108Lyophilized viral formulations
#1109Liquid viral formulations
#1110AAV's and uses thereof
#1111Recombinant poxvirus expressing homologous genes inserted
#1112Bacteriophage strains for the treatment of bacterial infections, especially drug resistant strains of the genus
#1113Polymer Conjugates with Decreased Antigenicity, Methods of Preparation and Uses Thereof
#1114Bacteriophage-containing therapeutic agents
#1115Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
#1116Process for producing poxviruses and poxvirus compositions
#1117METHODS AND COMPOSITIONS FOR THE TREATMENT OF CIRRHOSIS AND LIVER FIBROSIS
#1118Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
#1119IMAGING METHODS AND COMPOSITIONS COMPRISING FLUORESCENT DYES ASSOCIATED WITH VIRAL COMPONENTS FOR NERVE IMAGING
#1120Targeted gene delivery to dendritic cells
#1121DEFINED DOSE THERAPEUTIC PHAGE
#1122Compositions for preventing and treating uterine disease
#1123Antibacterial phage, phage peptides and methods of use thereof
#1124Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
#1125Preservation of bioactive materials by spray drying
#1126CNS delivery of therapeutic agents
#1127TUMOR THERAPY WITH ANTITUMOR AGENTS IN COMBINATION WITH SINDBIS VIRUS-BASED VECTORS
#1128Methods for Bacteriophage Design
#1129Bacteriophage compositions for treatment of bacterial infections
#1130Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#1131VIRUS GROWING IN HYPOXIC CELL OR VIRUS VECTOR EXPRESSING GENE THEREIN
#1132METHOD FOR TREATING PARKINSON'S DISEASE
#1133CELL RECEPTOR BLOCKER FOR PREVENTING AND TREATING AVIAN INFLUENZA AND OTHER DISEASES CAUSED BY VIRUSES
#1134Intergenic regions as insertion sites in the genome of modified vaccinia virus Ankara (MVA)
#1135Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
#1136Anti-viral protection with viruses containing defective genome segments
#1137Genomic sequence of avian paramyxovirus type 2 and uses thereof
#1138Engineered synergistic oncolytic viral symbiosis
#1139Method for bacteriophage delivery and amplification
#1140METHOD FOR TREATING DISEASE CHARACTERIZED BY PLAQUE
#1141ANTI-BACTERIA COMPOSITIONS
#1142Myxoma virus mutants for cancer treatment
#1143Method and filamentous phage for treating inflammation associated with amyloid deposits and brain inflammation involving activated microglia
#1144Recombinant Rift Valley fever (RVF) viruses and methods of use
#1145CANCER TREATMENT USING VIRUSES, FLUOROPYRIMIDINES AND CAMPTOTHECINS
#1146Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent
#1147Directed evolution and in vivo panning of virus vectors
#1148Desiccated biologics and methods of preparing the same
#1149ADAPTABLE MODIFIED VIRUS VECTOR TO DELIVER MODIFIED MESSENGER RIBONUCLEIC ACID AS A MEDICAL TREATMENT DEVICE TO MANAGE DIABETES MELLITUS AND OTHER PROTEIN DEFICIENT DISEASES
#1150ADAPTABLE MODIFIED VIRUS VECTOR TO DELIVER RIBOSOMAL RIBONUCLEIC ACID COMBINED WITH MESSENGER RIBONUCLEIC ACID AS A MEDICAL TREATMENT DEVICE TO MANAGE DIABETES MELLITUS AND OTHER PROTEIN DEFICIENT DIEASES
#1151ADAPTABLE MODIFIED VIRUS VECTOR TO DELIVER RIBOSOMAL RIBONUCLEIC ACID AS A MEDICAL TREATMENT DEVICE TO MANAGE DIABETES MELLITUS AND OTHER PROTEIN DEFICIENT DISEASES
#1152Reducing conjugative plasmids in bacteria
#1153Poxviral oncolytic vectors
#1154RECOMBINANT POXVIRUS EXPRESSING HOMOLOGOUS GENES INSERTED INTO THE POXVIRAL GENOME
#1155RECOMBINANT POXVIRUS EXPRESSING HOMOLOGOUS GENES INSERTED INTO THE POXVIRUS GENOME
#1156bacteriophage and antibacterial composition comprising the same
#1157NOVEL BACTERIOPHAGE AND ANTIBACTERIAL COMPOSITION COMPRISING THE SAME
#1158bacteriophage and antibacterial composition comprising the same
#1159NOVEL BACTERIOPHAGE AND ANTIBACTERIAL COMPOSITION COMPRISING THE SAME
#1160Pharmaceutical composition, use of the pharmaceutical composition for treating a brain tumor, production process thereof and a kit of parts comprising the pharmaceutical composition
#1161Desiccated Biologics And Methods Of Preparing The Same
#1162Bacteriophage-containing therapeutic agents
#1163Method for producing a mixture of bacteriophages and the use thereof in the therapy of antibiotic-resistant staphylococci
#1164Purified bacteriophage, its preparation and application
#1165Engineered bacteriophages as adjuvants for antimicrobial agents and compositions and methods of use thereof
#1166Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
#1167Replication-defective arenavirus vectors
#1168Bacteriophage preparations and methods of use thereof
#1169Combinations of Immunostimulatory Agents, Oncolytic Virus, and Additional Anticancer Therapy
#1170METHODS AND COMPOSITIONS RELATED TO PHAGE-NANOPARTICLE ASSEMBLIES
#1171BACTERIOPHAGE PREPARATION AND USE
#1172Respiratory syncytial virus with a genomic deficiency complemented in trans
#1173System comprising bacteriophages and particles that contain active substances
#1174Bacteriophage having killing activity specific to
#1175Parapoxviruses in combination with other antiviral agents for the treatment of viral diseases
#1176Bacteriophage or lytic protein derived from the bacteriophage which effective for the treatment of biofilm
#1177Microorganisms for imaging and/or treatment of tumors
#1178Bacteriophage and their uses
#1179Phage therapy against
#1180Decreasing cancer cell proliferation with WNT remaining active
#1181Viruses for the treatment of cellular proliferative disorders
#1182bacteriophage having killing activity specific to
#1183RECOMBINANT POXVIRUS EXPRESSING HOMOLOGOUS GENES INSERTED INTO THE POXVIRAL GENOME
#1184bacteriophage and antibacterial composition comprising the same
#1185Papillomavirus pseudoviruses for detection and therapy of tumors
#1186Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGN
#1187Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein
#1188Tyrosine-modified recombinant rAAV vector compositions and methods for use
#1189Beneficial effects of bacteriophage treatments
#1190Oncolytic Adenoviruses and Uses Thereof
#1191Bacteriophage preparations and method of use thereof
#1192Prevention of allergic sensitization
#1193Methods for identifying agents that affect the survival of motor neurons
#1194Agent for promoting the production of thioredoxin
#1195Pathotropic targeted gene delivery system for cancer and other disorders
#1196Isolated phages and their use in food or pet food products
#1197Process for producing poxviruses and poxvirus compositions
#1198Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
#1199Composition for the treatment of ballast water containing bacteriophage as an effective component and biological method with the same for removing bacteria present in ballast water
#1200Multi plasmid system for the production of influenza virus